Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design

Código QR

Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design

Guardado en:

Detalles Bibliográficos
Autores principales:	Haiying Qin, Nirali N Shah, Terry J Fry, Lila Yang, John A Chukinas, Samiksha Tarun, Marie Pouzolles, Christopher D Chien, Lisa M Niswander, Anthony R Welch, Sarah K Tasian, Naomi A Taylor
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/7341e3e04ef748e4ab7d4e2752aa2b98
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance
por: Sylvain Garciaz, et al.
Publicado: (2021)

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
por: Adriana E. Tron, et al.
Publicado: (2018)

Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
por: Nan Li, et al.
Publicado: (2021)

Circular RNAs in acute myeloid leukemia
por: Vijendra Singh, et al.
Publicado: (2021)

Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
por: Sara Small, et al.
Publicado: (2021)

Peptidomimetic blockade of MYB in acute myeloid leukemia
por: Kavitha Ramaswamy, et al.
Publicado: (2018)

NEW ADVANCES IN PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Özlem Tüfekçi
Publicado: (2021)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
por: O. V. Smirnova, et al.
Publicado: (2014)

Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease
por: Deepali K. Bhat, et al.
Publicado: (2021)

Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis
por: Meike Farber, et al.
Publicado: (2021)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
por: Radhakrishnan Ramchandren, et al.
Publicado: (2009)

The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia
por: Débora Bifano Pimenta, et al.
Publicado: (2021)

EXPERIENCE OF GLASDEGIB IN PATIENTS WITH ELDERLY ACUTE MYELOID LEUKEMIA
por: Nanişe Gizem FENER, et al.
Publicado: (2021)

Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients
por: Ibuki Harada, et al.
Publicado: (2021)

Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model.
por: Haneen Nur, et al.
Publicado: (2013)

Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
por: Feng Wang, et al.
Publicado: (2021)

Concurrent Onset of Chronic Lymphocytic Leukemia and Atypical Phenotype Acute Myeloid Leukemia Revealed by Autopsy
por: Sayaka Kiso, et al.
Publicado: (2021)

Arterial hypertension assessment in a population with chronic myeloid leukemia
por: Ricardo Roa-Chamorro, et al.
Publicado: (2021)

Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia
por: Christian M. Vonk, et al.
Publicado: (2021)

DISTRIBUTION PATTERN FOR HLA SPECIFICITIES IN THE PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: I. R. Ramilyeva, et al.
Publicado: (2019)

Emerging treatment approaches in acute lymphoblastic and acute myeloid leukemias
por: Thomas X
Publicado: (2012)

Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia
por: Shujuan Wang, et al.
Publicado: (2020)

CHRONIC MYELOID LEUKEMIA - CLINICAL AND IMMUNOLOGICAL PECULIARITIES IN ADULT PATIENTS
por: O. V. Smirnova
Publicado: (2012)

PONATINIB EXPERIENCE IN A PEDIATRIC CHRONIC MYELOID LEUKEMIA PATIENT
por: Serap Karaman, et al.
Publicado: (2021)

Leukemia Stem Cells as a Potential Target to Achieve Therapy-Free Remission in Chronic Myeloid Leukemia
por: Kyoko Ito, et al.
Publicado: (2021)

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Theodore P. Braun, et al.
Publicado: (2019)

Adoptive chimeric antigen receptor T cell (CAR-T) and Treg cell-based immunotherapies: Frontier therapeutic aspects in cancers
por: Mehran Bahraini, et al.
Publicado: (2021)

Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia
por: Furun An, et al.
Publicado: (2020)

Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients
por: Florent Malard, et al.
Publicado: (2021)

SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia
por: Can Yue, et al.
Publicado: (2021)

Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
por: Amin Huma, et al.
Publicado: (2021)

Targeting adhesion to the vascular niche to improve therapy for acute myeloid leukemia
por: Myriam L. R. Haltalli, et al.
Publicado: (2020)

Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia.
por: Michele Tanturli, et al.
Publicado: (2011)

Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives
por: Maximilian Fleischmann, et al.
Publicado: (2021)

Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia.
por: Carolyn Glass, et al.
Publicado: (2013)

Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
por: Sibylle Cocciardi, et al.
Publicado: (2019)

Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose
por: Waclaw J, et al.
Publicado: (2015)

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
por: Diletta Fontana, et al.
Publicado: (2021)

Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia
por: Yundeok Kim, et al.
Publicado: (2021)